Successful resuscitation after bolus injection of tissue-type plasminogen activator in the emergency room;Erfolgreiche reanimation nach bolusinjektion yon gewebe- plasminogenaktivator in der notaufnahme

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 33, Issue 2, 1998, Pages 124-128

  Schulte Sinkus, D ^a   Standl, Th ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Ambulance; Cardiopulmonary resuscitation; Pulmonary embolism; Thrombolytic therapy; Tissue type plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; EMERGENCY TREATMENT; RESUSCITATION; ADULT; AMBULATORY SURGERY; ARTHROSCOPY; DOSE RESPONSE; DRUG ADMINISTRATION; EMERGENCY; FEMALE; FIBRINOLYTIC THERAPY; HEART ARREST; HUMAN; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ADULT; AMBULATORY SURGICAL PROCEDURES; ARTHROSCOPY; CARDIOPULMONARY RESUSCITATION; CRITICAL CARE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EMERGENCIES; FEMALE; HEART ARREST; HUMANS; INFUSIONS, INTRAVENOUS; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; RESUSCITATION; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0031596647     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994226     Document Type: Article

References (30)

1. Böttiger BW, Böhrer H, Bach A, Motsch J, Martin E: Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation 1994; 28:45-54
2. Böttiger BW, Reim SM, Diezel G: Erfolgreiche Behandlung einer fulminanten Lungenembolie durch hochdosierte Bolusinjektion von Urokinase während der kardiopulmonalen Reanimation. Anaesthesiol. Intensivmed. Notfallmed. Schmerzther. 1991;26: 29-36
3. Böttiger BW, Reim SM, Diezel G, Böhrer H, Martin E: High-dose bolus injection of urokinase. Use during cardiopulmonary resuscitation for massive pulmonary embolism. Chest 1994;106: 1281-1283
4. Feied C: Pulmonary embolism: In: Rosen P, Barkin RM (eds.): Emergency Medicine. Concepts and Clinical Practice. Mosby Year Book, St. Louis 1992;2:1285-1311
5. Fischer M, Böttiger BW, Popov-Cenic S, Hossmann KA: Thrombolysis using plasminogen activator reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med. 1996;22:1214-1223
6. Fred HC, Yang M: Sudden loss of consciousness, dyspnea, and hypoxemia in a previously healthy young man. Circulation 1995; 91:3017-3019
7. Goldhaver SZ, Kessler CM, Heit JA, Markis J, Sharma GRVK, Dawley D, Nagel JS, Meyerovitz M, Kim D, Vaughan DE, Parker JA, Tumeh SS, Drum D, Loscalzo J, Reagan K, Selwyn AP, Anderson J, Braunwald E: Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 1988;2:293-298
8. Goldhaber SZ, Kessler CM, Heit JA, Elliott CG, Friedenberg WR, Heiselman DE, Wilson DB, Parker JA, Bennett D, Feldstein ML, Selwyn AP, Kim D, Sharma GVRK, Nagel JS, Meyerovitz MF: Recombinant Tissue-Type Plasminogen Activator Versus a Novel Dosing Regimen of Urokinase in Acute Pulmonary Embolism: A Randomized Controlled Multicenter Trial. J. Am. Coll. Cardiol. 1992;20:24-30
9. Grosser KD: Akute Lungenembolie. Dt. Ärztebl. 1988;85:587-594
10. Hirsch J: Heparin. N. Engl. J. Med. 1991;324:1565-1574
11. Hopf HB, Floßdorf T, Breulmann M: Rekombinanter Gewebeplasminogenaktivator (rt-PA) zur Notfallbehandlung der perioperativen lebensbedrohlichen Lungenembolie (Stadium 4). Anaesthesist 1991;40:309-314
12. Horstkotte D, Heintzen MP, Strauer BE: Kombinierte mechanische und thrombolytische Wiedereröffnung der Lungenstrombahn bei massiver Lungenarterienembolie mit kardiogenem Schock. Intensivmed 1990;27:124-132
13. Loscalzo J, Braunwald E: Tissue plasminogen activator. N. Engl. J. Med. 1988;319:925-931
14. Marder VJ, Sherry S: Thrombolyic Therapy: Current Status (second of two parts). N. Engl. J. Med. 1988;318:1585-1595
15. Meissner E, Fabel H: Akute Lungenembolie - Klinik, Diagnostik und Therapie. Arzneimitteltherapie 1990;8:177-192
16. Meissner E, Niedermeyer J, Fabel H: Akute Lungenembolie. Z. Kardiol. 1993;82, Suppl. 2:3-12
17. Meyer G, Sors H, Charbonnier B, Kasper W, Baussaud JP, Kerr IH, Lesaffre E, Vanhove P, Verstraete M: Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism. A European multicenter double-blind trial. J. Am. Coll Cardiol. 1992;19:239-245
18. Neuhaus KL, Feuerer W, Tebbe U, Jeep-Tebbe S, Vogt A: Efficacy of a 90-minute infusion of 100 mg tissue plasminogen activator (t-PA) in acute myocardial infarction. Eur. Heart J. 1988;9:67 A
19. Petitpretz P, Simmoneau G, Cerrina J, Musset D, Dreyfuss D, Vandenbroek MD, Duroux P: Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial. Circulation 1984;70:861-866
20. Purvis JA, Mc Neill AJ, Seddiqui RA, Roberts MJD, Mc Clements BM, Mc Eneaney D, Campbell NPS, Khan MM, Webb SW, Wilson CM, Adgey AAJ: Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction. J. Am. Coll. Cardiol. 1994;23:6-10
21. Renkes-Hegendörfer U, Hermann K: Erfolgreiche Behandlung einer massiven fulminanten Lungenembolie durch Streptokinase. Anaesthesist 1974;23:500-501
22. Rix EW, Stahl C, Schäfer F, Seifert G: Systemische Lysetherapie mit rekombinantem Gewebe-Plasminogen-Aktivator bei fulminanter Lungenembolie. Dtsch. Med. Wschr. 1990;115:257-260
23. Schmid C, Zietlow S, Wagner TO, Laas J, Borst HG: Fulminant pulmonary embolism: symptoms, diagnostics, operative technique, and results. Ann. Thorac. Surg. 1991;52:1102-1105
24. Schmutzler R: Rekombinanter "tissue-type" Plasminogenaktivator (rt-PA) bei Lungenembolie. Hämostaseologie 1988;8:223-225
25. Scholz KH, Hilmer T, Schuster S, Wojik J, Kreuzer H, Tebbe U: Thrombolyse bei reanimierten Patienten mit Lungenembolie. Dtsch. Med. Wschr. 1990;115:930-935
26. Siebenlist D, Gattenlöhner W: Kurzzeitlyse mit rt-PA bei fulminanter Lungenembolie. Intensivmed. 1990;27:302-305
27. UPET: Urokinase Pulmonary Embolism Trial: A cooperative study. J. Am. Med. Ass. 1970;214:2163-2168
28. UPSET: Urokinase-Streptokinase Pulmonary Embolism Trial: A cooperative study. J. Am. med. Ass. 1974;229:1606-1613
29. Verstraete M, Müller GAH, Bounameaux H, Charbonnier B, Colle JP, Lecorf G, Marbet GA, Mombaerts P, Olsson CG: Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988;77:353-360
30. Zimmermann R, Schwarz F: Streptokinase versus Urokinase bei massiver Lungenembolie: In: Beck EA (Hrsg): Thrombose und Hämostaseforschung. Schattauer Stuttgart-New York 1984;67